Jürgen Siebler

2.3k total citations
60 papers, 1.1k citations indexed

About

Jürgen Siebler is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jürgen Siebler has authored 60 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 21 papers in Surgery and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jürgen Siebler's work include Colorectal Cancer Treatments and Studies (11 papers), Gastric Cancer Management and Outcomes (10 papers) and Hepatocellular Carcinoma Treatment and Prognosis (8 papers). Jürgen Siebler is often cited by papers focused on Colorectal Cancer Treatments and Studies (11 papers), Gastric Cancer Management and Outcomes (10 papers) and Hepatocellular Carcinoma Treatment and Prognosis (8 papers). Jürgen Siebler collaborates with scholars based in Germany, United States and United Kingdom. Jürgen Siebler's co-authors include Markus F. Neurath, Peter R. Galle, Georg Kochs, Otto Haller, Raja Atreya, Michael Frese, Stefan Wirtz, Philippe Merle, Michael Lahn and Yumin Zhao and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Jürgen Siebler

57 papers receiving 1.1k citations

Peers

Jürgen Siebler
Keith Lai United States
Núria Planell Spain
Keiko Kaneko Japan
Colette Charland United States
Miao Xu China
Purnima Bhat Australia
Michail Schizas United States
Nicholas Sanderson United Kingdom
Brigitte Bartsch Germany
Ih Jen Su Taiwan
Keith Lai United States
Jürgen Siebler
Citations per year, relative to Jürgen Siebler Jürgen Siebler (= 1×) peers Keith Lai

Countries citing papers authored by Jürgen Siebler

Since Specialization
Citations

This map shows the geographic impact of Jürgen Siebler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jürgen Siebler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jürgen Siebler more than expected).

Fields of papers citing papers by Jürgen Siebler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jürgen Siebler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jürgen Siebler. The network helps show where Jürgen Siebler may publish in the future.

Co-authorship network of co-authors of Jürgen Siebler

This figure shows the co-authorship network connecting the top 25 collaborators of Jürgen Siebler. A scholar is included among the top collaborators of Jürgen Siebler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jürgen Siebler. Jürgen Siebler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fietkau, Rainer, Jürgen Siebler, Marianne Pavel, et al.. (2024). A Hybrid Type III Effectiveness-Implementation Trial to Optimize Medication Safety With Oral Antitumor Therapy in Real-World: The AMBORA Competence and Consultation Center. JCO Oncology Practice. 20(9). 1219–1230. 1 indexed citations
2.
Jacobsen, Anne, Jürgen Siebler, Robert Grützmann, Michael Stürzl, & Elisabeth Naschberger. (2024). Blood Vessel-Targeted Therapy in Colorectal Cancer: Current Strategies and Future Perspectives. Cancers. 16(5). 890–890. 6 indexed citations
3.
Vogel, Arndt, Anna Saborowski, Gabriele Margareta Siegler, et al.. (2023). 955P IMMUNIB trial (AIO-HEP-0218/ass): A single-arm phase II study evaluating safety and efficacy of immunotherapy with nivolumab in combination with lenvatinib in advanced hepatocellular carcinoma. Annals of Oncology. 34. S598–S598. 1 indexed citations
4.
Siebler, Jürgen, et al.. (2022). Efficacy and Safety of Angioplasty Balloon Interposition in CT-Guided Percutaneous Thermal Ablation of Hepatic Malignancies to Protect Adjacent Organs. CardioVascular and Interventional Radiology. 45(9). 1401–1407. 4 indexed citations
5.
Fritz, Valerie, Andreas E. Kremer, Wolfgang E. Thasler, et al.. (2021). Combined De-Repression of Chemoresistance Associated Mitogen-Activated Protein Kinase 14 and Activating Transcription Factor 2 by Loss of microRNA-622 in Hepatocellular Carcinoma. Cancers. 13(5). 1183–1183. 5 indexed citations
6.
Vitali, Francesco, Axel Wein, Timo Räth, et al.. (2021). The outcome of patients with inflammatory bowel disease–associated colorectal cancer is not worse than that of patients with sporadic colorectal cancer–a matched-pair analysis of survival. International Journal of Colorectal Disease. 37(2). 381–391. 6 indexed citations
7.
8.
Vitali, Francesco, Andreas Nägel, Lukáš Pfeifer, et al.. (2021). Endoscopic recanalization of complete esophageal obstruction. Surgical Endoscopy. 35(6). 3184–3188.
9.
10.
Merkel, Susanne, Klaus Weber, Roland S. Croner, et al.. (2016). Distant metastases in colorectal carcinoma: A proposal for a new M1 subclassification. European Journal of Surgical Oncology. 42(9). 1337–1342. 15 indexed citations
11.
Wein, Axel, Jürgen Siebler, Ruediger S. Goertz, et al.. (2016). Successful Multidisciplinary Treatment with Secondary Metastatic Liver Resection after Downsizing by Palliative Second-Line Treatment of Colorectal Cancer: A Curative Option. Case Reports in Oncology. 9(2). 379–386. 1 indexed citations
12.
Dornhoff, Heike, Christoph Becker, Stefan Wirtz, et al.. (2012). A Variant of Smurf2 Protects Mice Against Colitis-Associated Colon Cancer by Inducing Transforming Growth Factor β Signaling. Gastroenterology. 142(5). 1183–1194.e4. 7 indexed citations
13.
Neumann, Helmut, Michael Vieth, Raja Atreya, et al.. (2012). Assessment of Crohnʼs disease activity by confocal laser endomicroscopy. Inflammatory Bowel Diseases. 18(12). 2261–2269. 73 indexed citations
14.
Neumann, Helmut, Florian Fuchs, M Vieth, et al.. (2011). Review article: in vivo imaging by endocytoscopy. Alimentary Pharmacology & Therapeutics. 33(11). 1183–1193. 73 indexed citations
15.
Schattenberg, Jörn M., Tim Zimmermann, Marcus A. Wörns, et al.. (2011). Ablation of c-FLIP in hepatocytes enhances death-receptor mediated apoptosis and toxic liver injury in vivo. Journal of Hepatology. 55(6). 1272–1280. 53 indexed citations
16.
Wein, Axel, Heinz Albrecht, Kerstin Wolff, et al.. (2011). Long-Term Relapse-Free Survival by Interdisciplinary Collaboration in a Patient with Metastatic Pancreatic Cancer (UICC IV). SHILAP Revista de lepidopterología. 4(2). 413–419. 1 indexed citations
17.
Moehler, Markus, Karl Verpoort, Christoph Maintz, et al.. (2010). Efficacy and Safety of Irinotecan-Based Chemotherapy for Advanced Colorectal Cancer outside Clinical Trials: An Observational Study. Onkologie. 33(12). 684–690. 3 indexed citations
18.
Siebler, Jürgen, Ulrike Protzer, Stefan Wirtz, et al.. (2006). Overexpression of STAT-1 by adenoviral gene transfer does not inhibit hepatitis B virus replication. European Journal of Gastroenterology & Hepatology. 18(2). 167–174. 2 indexed citations
19.
Teufel, Andreas, Jürgen Siebler, Herbert Hohl, et al.. (2004). Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer. BMC Cancer. 4(1). 38–38. 30 indexed citations
20.
Siebler, Jürgen, Otto Haller, & Georg Kochs. (1996). Thogoto and Dhori virus replication is blocked by inhibitors of cellular polymerase II activity but does not cause shutoff of host cell protein synthesis. Archives of Virology. 141(8). 1587–1594. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keith Lai Breakdown of academic impact, for papers by Núria Planell Breakdown of academic impact, for papers by Keiko Kaneko Breakdown of academic impact, for papers by Colette Charland Breakdown of academic impact, for papers by Miao Xu Breakdown of academic impact, for papers by Purnima Bhat Breakdown of academic impact, for papers by Michail Schizas Breakdown of academic impact, for papers by Nicholas Sanderson Breakdown of academic impact, for papers by Brigitte Bartsch Breakdown of academic impact, for papers by Ih Jen Su
Rankless by CCL
2026